Growth Metrics

Collegium Pharmaceutical (COLL) Cash from Operations (2016 - 2025)

Collegium Pharmaceutical has reported Cash from Operations over the past 10 years, most recently at 123048000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 123048000.0 for Q4 2025, up 45.37% from a year ago — trailing twelve months through Dec 2025 was 329323000.0 (up 60.66% YoY), and the annual figure for FY2025 was 329323000.0, up 60.66%.
  • Cash from Operations for Q4 2025 was 123048000.0 at Collegium Pharmaceutical, up from 78438000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for COLL hit a ceiling of 123048000.0 in Q4 2025 and a floor of 25315000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 58667500.0 (2024), compared with a mean of 51841950.0.
  • Biggest five-year swings in Cash from Operations: tumbled 223.07% in 2022 and later soared 971.63% in 2025.
  • Collegium Pharmaceutical's Cash from Operations stood at 36198000.0 in 2021, then skyrocketed by 83.23% to 66325000.0 in 2022, then grew by 10.57% to 73338000.0 in 2023, then increased by 15.42% to 84644000.0 in 2024, then surged by 45.37% to 123048000.0 in 2025.
  • The last three reported values for Cash from Operations were 123048000.0 (Q4 2025), 78438000.0 (Q3 2025), and 72439000.0 (Q2 2025) per Business Quant data.